Ana Ciobanu

5 ta ish

World Health Organization Regional Office for Europe

1. Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis

   Aleksandr Trubnikov, Arax Hovhannesyan, Kristina Akopyan +5

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20212 iqtibos

   ABIABI:AkademIndex/2026.other.262608

2. Risk Factors for Unfavorable Treatment Outcomes among the Human Immunodeficiency Virus-Associated Tuberculosis Population in Tashkent City, Uzbekistan: 2013–2017

   Sherali Massavirov, Kristina Akopyan, Fazlkhan Abdugapparov +5

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20211 iqtibos

   ABIABI:AkademIndex/2026.other.262610

3. Characteristics and Treatment Outcomes of Patients with Tuberculosis Receiving Adjunctive Surgery in Uzbekistan

   Anvar Riskiyev, Ana Ciobanu, Arax Hovhannesyan +3

   MaqolaOAOchiq kirishDiagnosis and treatment of tuberculosisInternational Journal of Environmental Research and Public Health20210 iqtibos

   ABIABI:AkademIndex/2021.article.000700

4. Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study

   Oleksandr Korotych, Jay Achar, Elmira Gurbanova +23

   MaqolaOAOchiq kirish20240 iqtibos

   ABIABI:AkademIndex/2024.article.018556

5. Effectiveness and Safety of Modified Fully Oral Nine-Month Treatment Regimens for Rifampicin-Resistant Tuberculosis: Prospective Cohort Study

   Oleksandr Korotych, Jay Achar, Elmira Gurbanova +23

   PreprintOAOchiq kirishTuberculosis Research and EpidemiologySSRN Electronic Journal20240 iqtibos

   ABIABI:AkademIndex/2024.preprint.000046